Paul M. Grand is Director, Pacific Coast for RCT BioVentures, a technology venture investment firm and management company that provides early-stage venture funding for promising biomedical companies and technologies. RCT has assets of more than $300 million to advance technology and product development. Prior to joining RCT, Grand was co-founder and VP of Operations of Imagine Pharmaceuticals. Imagine is developing a platform to selectively deliver therapeutics and other compounds across the blood brain barrier. He was also co-founder and CEO of MicroSurgeon in Los Angeles. MicroSurgeon is developing a microwave thermal ablation device for the treatment of solid tumors.

Grand has extensive experience in new company formation and fund raising. Since 1990, he has built, operated, recruited management and raised financing for eight high technology, medical device and biotechnology companies. He has employed more than 300 people in the Los Angeles area and served as CEO in companies with up to 150 employees. Grand also was a managing director for Fruition Ventures, a group of private equity investors focused primarily on early-stage information technology companies.

Grand is a frequent panelist at biomedical conferences, and he is a member of the Los Angeles Life Science Roundtable. Grand has lectured on entrepreneurship and venture funding to faculty, students and scientists at the University of California in Los Angeles, and he serves as an investment advisor to the LARTA NIH Commercialization Assistance Program for National Institute of Health Phase II Small Business Innovation Research (SBIR) program awardees. Grand has spoken at more than 100 conferences, been featured in hundreds of articles in publications including Forbes, New York Times and Wall Street Journal and appeared as an expert on Bloomberg Television, CNN, and CNN/FN.

Team
Board Members
Investment Committee
Global Advisory Council

contact us | terms of use | site map | privacy policy | jobs